Review




Structured Review

Pyrosequencing Inc luma (pyrosequencing)
Articles assessing global DNA methylation in response to pesticide exposure
Luma (Pyrosequencing), supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luma+(pyrosequencing)/luma++pyrosequencing+/pmc11110075-1-15-16
Average 90 stars, based on 1 article reviews
luma (pyrosequencing) - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Epigenetic processes involved in response to pesticide exposure in human populations: a systematic review and meta-analysis"

Article Title: Epigenetic processes involved in response to pesticide exposure in human populations: a systematic review and meta-analysis

Journal: Environmental Epigenetics

doi: 10.1093/eep/dvae005

Articles assessing global DNA methylation in response to pesticide exposure
Figure Legend Snippet: Articles assessing global DNA methylation in response to pesticide exposure

Techniques Used: DNA Methylation Assay, Pesticides, Mass Spectrometry, Isotope Dilution, Liquid Chromatography, Gas Chromatography, Clinical Proteomics, Gas Chromatography-Mass Spectrometry, Methylation, Chromatography

Related Articles

CpG Methylation Assay:

Article Title: Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach
Article Snippet: .. Since Dusp9 has been suggested to be responsible for the reduction of global CpG methylation levels typically observed in female mESCs (20–30% compared to 60–80% in male mESCs) [ , , ], we analyzed how over-expression of Dusp9 and Klhl13 affected global DNA methylation through the pyrosequencing-based luminometric DNA methylation assay (LUMA; Fig. g). ..

Article Title: Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach
Article Snippet: .. Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA). ..

DNA Methylation Assay:

Article Title: Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach
Article Snippet: .. Since Dusp9 has been suggested to be responsible for the reduction of global CpG methylation levels typically observed in female mESCs (20–30% compared to 60–80% in male mESCs) [ , , ], we analyzed how over-expression of Dusp9 and Klhl13 affected global DNA methylation through the pyrosequencing-based luminometric DNA methylation assay (LUMA; Fig. g). ..

Article Title: Disagreement between two common biomarkers of global DNA methylation
Article Snippet: .. The two different global DNA methylation markers (LINE-1 pyrosequencing, LUMA) were assessed in three independent sample sets that were generated (i) in vitro from human cell lines (MCF7 and SHSY5Y) or (ii) whole blood samples acquired from healthy volunteers (one set) or (iii) pain patients (two sets). ..

Article Title: Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach
Article Snippet: .. Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA). ..

Article Title: Impact of Physical Activity on DNA Methylation Signatures in Breast Cancer Patients: A Systematic Review with Bioinformatic Analysis
Article Snippet: McCullough et al., 2015 (specific) [ ] , Population-based-case–control study , Female first primary BC patients ( n = 532) (20–98 years of age, mean age 59.6) , Breast tumour sample , RPA , -MSP: ESR1, PR, BRCA1 -MethyLight assay: APC, CDH1, CCND2, DAPK, GSTP1, HIN, P16, RARB, RASSF1A, TWIST1 , GSTP1. .. McCullough et al., 2015 (global) [ ] , Population-based-case–control study , Postmenopausal female first primary BC ( n = 1300) (20–98 years of age) , Blood sample , Postmenopausal RPA , LUMA global DNA methylation assay: LUMA Pyrosequencing-based methylation assay: LINE-1 , Global DNA methylation. .. McCullough et al., 2017 [ ] , Population-based-case–control study , Female first primary BC patients ( n = 807) (20–98 years of age) , Breast tumour sample Blood sample , RPA , Gene-specific: -MSP: ESR1, PR, BRCA1 -MethyLight assay: APC, CDH1, CCND2, DAPK, GSTP1, HIN, P16, RARB, RASSF1A, TWIST1 Global: -LUMA global DNA methylation assay: LUMA -Pyrosequencing-based methylation assay: LINE-1 , APC, CCND2, HIN, TWIST1.

other:

Article Title: Epigenetic processes involved in response to pesticide exposure in human populations: a systematic review and meta-analysis
Article Snippet: Itoh et al ., [ ] , Cross-sectional , DNA methylation in peripheral leukocytes , LUMA (pyrosequencing) , 403 Japanese women , High-resolution mass spectrometer with selected ion monitoring coupled to a gas chromatograph, based on isotope dilution mass spectrometry , β-HCH, pp' -DDE, cis -heptachlor epoxide, trans -nonachlor ( trans -nonachlordane), pp' -DDD (dichlorodiphenyldichloroethane, pp' -DDT dichlorodiphenyltrichloroethane , Global hypomethylation.

Article Title: Predictors and Consequences of Global DNA Methylation in Cord Blood and at Three Years
Article Snippet: Wu et al. described global DNA methylation in peripheral blood mononuclear cells (a subset of total WBC) measured three ways (LUMA, LINE-1 by pyrosequencing and Sat2 by methylite) in adults at two time points 8.6 years apart.

Article Title: In Utero Exposure to Metformin Reduces the Fertility of Male Offspring in Adulthood
Article Snippet: The global methylation level of each DNA sample was measured using Luminometric Methylation Assay (LUMA), a pyrosequencing-based method , in two independent experiments.

Article Title: DNA Methylation Analysis: Choosing the Right Method.
Article Snippet: 1.3 ELISA-based 1.5 RFLP; AFLP 1.6 LUMA (digest + pyrosequencing extension) 2.2 Microarray or bead array 3.4 Methylationspecific PCR 3.5 HRM 3.6 COLD-PCR 3.2 PCR and sequencing No Yes Are candidate genes known?

Generated:

Article Title: Disagreement between two common biomarkers of global DNA methylation
Article Snippet: .. The two different global DNA methylation markers (LINE-1 pyrosequencing, LUMA) were assessed in three independent sample sets that were generated (i) in vitro from human cell lines (MCF7 and SHSY5Y) or (ii) whole blood samples acquired from healthy volunteers (one set) or (iii) pain patients (two sets). ..

In Vitro:

Article Title: Disagreement between two common biomarkers of global DNA methylation
Article Snippet: .. The two different global DNA methylation markers (LINE-1 pyrosequencing, LUMA) were assessed in three independent sample sets that were generated (i) in vitro from human cell lines (MCF7 and SHSY5Y) or (ii) whole blood samples acquired from healthy volunteers (one set) or (iii) pain patients (two sets). ..

Standard Deviation:

Article Title: Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach
Article Snippet: .. Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA). ..

Recombinase Polymerase Amplification:

Article Title: Impact of Physical Activity on DNA Methylation Signatures in Breast Cancer Patients: A Systematic Review with Bioinformatic Analysis
Article Snippet: McCullough et al., 2015 (specific) [ ] , Population-based-case–control study , Female first primary BC patients ( n = 532) (20–98 years of age, mean age 59.6) , Breast tumour sample , RPA , -MSP: ESR1, PR, BRCA1 -MethyLight assay: APC, CDH1, CCND2, DAPK, GSTP1, HIN, P16, RARB, RASSF1A, TWIST1 , GSTP1. .. McCullough et al., 2015 (global) [ ] , Population-based-case–control study , Postmenopausal female first primary BC ( n = 1300) (20–98 years of age) , Blood sample , Postmenopausal RPA , LUMA global DNA methylation assay: LUMA Pyrosequencing-based methylation assay: LINE-1 , Global DNA methylation. .. McCullough et al., 2017 [ ] , Population-based-case–control study , Female first primary BC patients ( n = 807) (20–98 years of age) , Breast tumour sample Blood sample , RPA , Gene-specific: -MSP: ESR1, PR, BRCA1 -MethyLight assay: APC, CDH1, CCND2, DAPK, GSTP1, HIN, P16, RARB, RASSF1A, TWIST1 Global: -LUMA global DNA methylation assay: LUMA -Pyrosequencing-based methylation assay: LINE-1 , APC, CCND2, HIN, TWIST1.

Methylation:

Article Title: Impact of Physical Activity on DNA Methylation Signatures in Breast Cancer Patients: A Systematic Review with Bioinformatic Analysis
Article Snippet: McCullough et al., 2015 (specific) [ ] , Population-based-case–control study , Female first primary BC patients ( n = 532) (20–98 years of age, mean age 59.6) , Breast tumour sample , RPA , -MSP: ESR1, PR, BRCA1 -MethyLight assay: APC, CDH1, CCND2, DAPK, GSTP1, HIN, P16, RARB, RASSF1A, TWIST1 , GSTP1. .. McCullough et al., 2015 (global) [ ] , Population-based-case–control study , Postmenopausal female first primary BC ( n = 1300) (20–98 years of age) , Blood sample , Postmenopausal RPA , LUMA global DNA methylation assay: LUMA Pyrosequencing-based methylation assay: LINE-1 , Global DNA methylation. .. McCullough et al., 2017 [ ] , Population-based-case–control study , Female first primary BC patients ( n = 807) (20–98 years of age) , Breast tumour sample Blood sample , RPA , Gene-specific: -MSP: ESR1, PR, BRCA1 -MethyLight assay: APC, CDH1, CCND2, DAPK, GSTP1, HIN, P16, RARB, RASSF1A, TWIST1 Global: -LUMA global DNA methylation assay: LUMA -Pyrosequencing-based methylation assay: LINE-1 , APC, CCND2, HIN, TWIST1.



Similar Products

90
Pyrosequencing Inc luma (pyrosequencing)
Articles assessing global DNA methylation in response to pesticide exposure
Luma (Pyrosequencing), supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luma+(pyrosequencing)/luma++pyrosequencing+/pmc11110075-1-15-16
Average 90 stars, based on 1 article reviews
luma (pyrosequencing) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based luminometric dna methylation assay (luma)
Over-expression of Klhl13 and Dusp9 in male mESCs leads to an enhanced pluripotency state and slower differentiation kinetics. a Schematic representation of the dCas9-SunTag system used for gene activation. b–e To over-express Dusp9 (yellow) and Klhl13 (blue), male E14 mESCs, stably expressing the doxycycline-inducible SunTag system, were either transduced with one of two different sgRNAs targeting the respective promoter regions or with non-targeting control (NT) sgRNAs and were treated for 3 days with 1 μg/ml doxycycline as indicated. Protein levels of Dusp9 (left) and Klhl13 (right) were quantified via immunoblotting ( b ), expression levels of MAPK target genes Spry4 and Egr1 ( c ) and of naive pluripotency factors Nanog and Prdm14 ( e ) were assessed by qPCR and phosphorylation of Mek and Erk was quantified by immunoblotting ( d ). The immunoblot signals were normalized to Tubulin ( b ) or to total Mek/Erk ( d ) and to the mean of two doxycycline-treated non-targeting control sgRNAs. qPCR measurements were normalized to two housekeeping genes and to the respective untreated control (−Dox). Dots and triangles depict individual measurements of the two different sgRNAs, and thick bars show the mean of three biological replicates. f Dusp9- and Klhl13 over-expressing mESCs were treated with 1 μg/ml doxycycline 24 h before differentiation via LIF withdrawal for 4 days, and expression levels of pluripotency factors were measured by qPCR at different time points as indicated. Mean and standard deviation across 3 biological replicates is shown. g Global CpG <t>methylation</t> levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based <t>luminometric</t> <t>DNA</t> methylation assay (LUMA). * p < 0.05 in a two-tailed paired Student’s t test comparing the Dusp9/Klhl13 over-expressing samples and the non-targeting controls (mean of sgRNA1 and sgRNA2)
Pyrosequencing Based Luminometric Dna Methylation Assay (Luma), supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luma+(pyrosequencing)/luma++luminometric+methylation+assay+/pmc08051100-133-32-31
Average 90 stars, based on 1 article reviews
pyrosequencing-based luminometric dna methylation assay (luma) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc pyrosequencing-based luminometric dna methylation assay luma
Over-expression of Klhl13 and Dusp9 in male mESCs leads to an enhanced pluripotency state and slower differentiation kinetics. a Schematic representation of the dCas9-SunTag system used for gene activation. b–e To over-express Dusp9 (yellow) and Klhl13 (blue), male E14 mESCs, stably expressing the doxycycline-inducible SunTag system, were either transduced with one of two different sgRNAs targeting the respective promoter regions or with non-targeting control (NT) sgRNAs and were treated for 3 days with 1 μg/ml doxycycline as indicated. Protein levels of Dusp9 (left) and Klhl13 (right) were quantified via immunoblotting ( b ), expression levels of MAPK target genes Spry4 and Egr1 ( c ) and of naive pluripotency factors Nanog and Prdm14 ( e ) were assessed by qPCR and phosphorylation of Mek and Erk was quantified by immunoblotting ( d ). The immunoblot signals were normalized to Tubulin ( b ) or to total Mek/Erk ( d ) and to the mean of two doxycycline-treated non-targeting control sgRNAs. qPCR measurements were normalized to two housekeeping genes and to the respective untreated control (−Dox). Dots and triangles depict individual measurements of the two different sgRNAs, and thick bars show the mean of three biological replicates. f Dusp9- and Klhl13 over-expressing mESCs were treated with 1 μg/ml doxycycline 24 h before differentiation via LIF withdrawal for 4 days, and expression levels of pluripotency factors were measured by qPCR at different time points as indicated. Mean and standard deviation across 3 biological replicates is shown. g Global CpG <t>methylation</t> levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based <t>luminometric</t> <t>DNA</t> methylation assay (LUMA). * p < 0.05 in a two-tailed paired Student’s t test comparing the Dusp9/Klhl13 over-expressing samples and the non-targeting controls (mean of sgRNA1 and sgRNA2)
Pyrosequencing Based Luminometric Dna Methylation Assay Luma, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luma+(pyrosequencing)/luma++luminometric+methylation+assay+/pmc08051100-148-47-46
Average 90 stars, based on 1 article reviews
pyrosequencing-based luminometric dna methylation assay luma - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pyrosequencing Inc restriction enzyme and bisulphite-pyrosequencing–based luminometric methylation assay (luma)
Over-expression of Klhl13 and Dusp9 in male mESCs leads to an enhanced pluripotency state and slower differentiation kinetics. a Schematic representation of the dCas9-SunTag system used for gene activation. b–e To over-express Dusp9 (yellow) and Klhl13 (blue), male E14 mESCs, stably expressing the doxycycline-inducible SunTag system, were either transduced with one of two different sgRNAs targeting the respective promoter regions or with non-targeting control (NT) sgRNAs and were treated for 3 days with 1 μg/ml doxycycline as indicated. Protein levels of Dusp9 (left) and Klhl13 (right) were quantified via immunoblotting ( b ), expression levels of MAPK target genes Spry4 and Egr1 ( c ) and of naive pluripotency factors Nanog and Prdm14 ( e ) were assessed by qPCR and phosphorylation of Mek and Erk was quantified by immunoblotting ( d ). The immunoblot signals were normalized to Tubulin ( b ) or to total Mek/Erk ( d ) and to the mean of two doxycycline-treated non-targeting control sgRNAs. qPCR measurements were normalized to two housekeeping genes and to the respective untreated control (−Dox). Dots and triangles depict individual measurements of the two different sgRNAs, and thick bars show the mean of three biological replicates. f Dusp9- and Klhl13 over-expressing mESCs were treated with 1 μg/ml doxycycline 24 h before differentiation via LIF withdrawal for 4 days, and expression levels of pluripotency factors were measured by qPCR at different time points as indicated. Mean and standard deviation across 3 biological replicates is shown. g Global CpG <t>methylation</t> levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based <t>luminometric</t> <t>DNA</t> methylation assay (LUMA). * p < 0.05 in a two-tailed paired Student’s t test comparing the Dusp9/Klhl13 over-expressing samples and the non-targeting controls (mean of sgRNA1 and sgRNA2)
Restriction Enzyme And Bisulphite Pyrosequencing–Based Luminometric Methylation Assay (Luma), supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luma+(pyrosequencing)/restriction+enzyme+and+bisulphite+pyrosequencing+based+luminometric+methylation+assay++luma+/10__1158_slash_1940___6207__capr___12___0316-117-11-14
Average 90 stars, based on 1 article reviews
restriction enzyme and bisulphite-pyrosequencing–based luminometric methylation assay (luma) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Articles assessing global DNA methylation in response to pesticide exposure

Journal: Environmental Epigenetics

Article Title: Epigenetic processes involved in response to pesticide exposure in human populations: a systematic review and meta-analysis

doi: 10.1093/eep/dvae005

Figure Lengend Snippet: Articles assessing global DNA methylation in response to pesticide exposure

Article Snippet: Itoh et al ., [ ] , Cross-sectional , DNA methylation in peripheral leukocytes , LUMA (pyrosequencing) , 403 Japanese women , High-resolution mass spectrometer with selected ion monitoring coupled to a gas chromatograph, based on isotope dilution mass spectrometry , β-HCH, pp' -DDE, cis -heptachlor epoxide, trans -nonachlor ( trans -nonachlordane), pp' -DDD (dichlorodiphenyldichloroethane, pp' -DDT dichlorodiphenyltrichloroethane , Global hypomethylation.

Techniques: DNA Methylation Assay, Pesticides, Mass Spectrometry, Isotope Dilution, Liquid Chromatography, Gas Chromatography, Clinical Proteomics, Gas Chromatography-Mass Spectrometry, Methylation, Chromatography

Over-expression of Klhl13 and Dusp9 in male mESCs leads to an enhanced pluripotency state and slower differentiation kinetics. a Schematic representation of the dCas9-SunTag system used for gene activation. b–e To over-express Dusp9 (yellow) and Klhl13 (blue), male E14 mESCs, stably expressing the doxycycline-inducible SunTag system, were either transduced with one of two different sgRNAs targeting the respective promoter regions or with non-targeting control (NT) sgRNAs and were treated for 3 days with 1 μg/ml doxycycline as indicated. Protein levels of Dusp9 (left) and Klhl13 (right) were quantified via immunoblotting ( b ), expression levels of MAPK target genes Spry4 and Egr1 ( c ) and of naive pluripotency factors Nanog and Prdm14 ( e ) were assessed by qPCR and phosphorylation of Mek and Erk was quantified by immunoblotting ( d ). The immunoblot signals were normalized to Tubulin ( b ) or to total Mek/Erk ( d ) and to the mean of two doxycycline-treated non-targeting control sgRNAs. qPCR measurements were normalized to two housekeeping genes and to the respective untreated control (−Dox). Dots and triangles depict individual measurements of the two different sgRNAs, and thick bars show the mean of three biological replicates. f Dusp9- and Klhl13 over-expressing mESCs were treated with 1 μg/ml doxycycline 24 h before differentiation via LIF withdrawal for 4 days, and expression levels of pluripotency factors were measured by qPCR at different time points as indicated. Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA). * p < 0.05 in a two-tailed paired Student’s t test comparing the Dusp9/Klhl13 over-expressing samples and the non-targeting controls (mean of sgRNA1 and sgRNA2)

Journal: Genome Biology

Article Title: Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach

doi: 10.1186/s13059-021-02321-2

Figure Lengend Snippet: Over-expression of Klhl13 and Dusp9 in male mESCs leads to an enhanced pluripotency state and slower differentiation kinetics. a Schematic representation of the dCas9-SunTag system used for gene activation. b–e To over-express Dusp9 (yellow) and Klhl13 (blue), male E14 mESCs, stably expressing the doxycycline-inducible SunTag system, were either transduced with one of two different sgRNAs targeting the respective promoter regions or with non-targeting control (NT) sgRNAs and were treated for 3 days with 1 μg/ml doxycycline as indicated. Protein levels of Dusp9 (left) and Klhl13 (right) were quantified via immunoblotting ( b ), expression levels of MAPK target genes Spry4 and Egr1 ( c ) and of naive pluripotency factors Nanog and Prdm14 ( e ) were assessed by qPCR and phosphorylation of Mek and Erk was quantified by immunoblotting ( d ). The immunoblot signals were normalized to Tubulin ( b ) or to total Mek/Erk ( d ) and to the mean of two doxycycline-treated non-targeting control sgRNAs. qPCR measurements were normalized to two housekeeping genes and to the respective untreated control (−Dox). Dots and triangles depict individual measurements of the two different sgRNAs, and thick bars show the mean of three biological replicates. f Dusp9- and Klhl13 over-expressing mESCs were treated with 1 μg/ml doxycycline 24 h before differentiation via LIF withdrawal for 4 days, and expression levels of pluripotency factors were measured by qPCR at different time points as indicated. Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA). * p < 0.05 in a two-tailed paired Student’s t test comparing the Dusp9/Klhl13 over-expressing samples and the non-targeting controls (mean of sgRNA1 and sgRNA2)

Article Snippet: Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA).

Techniques: Over Expression, Activation Assay, Stable Transfection, Expressing, Transduction, Control, Western Blot, Phospho-proteomics, Standard Deviation, CpG Methylation Assay, DNA Methylation Assay, Two Tailed Test

Over-expression of Klhl13 and Dusp9 in male mESCs leads to an enhanced pluripotency state and slower differentiation kinetics. a Schematic representation of the dCas9-SunTag system used for gene activation. b–e To over-express Dusp9 (yellow) and Klhl13 (blue), male E14 mESCs, stably expressing the doxycycline-inducible SunTag system, were either transduced with one of two different sgRNAs targeting the respective promoter regions or with non-targeting control (NT) sgRNAs and were treated for 3 days with 1 μg/ml doxycycline as indicated. Protein levels of Dusp9 (left) and Klhl13 (right) were quantified via immunoblotting ( b ), expression levels of MAPK target genes Spry4 and Egr1 ( c ) and of naive pluripotency factors Nanog and Prdm14 ( e ) were assessed by qPCR and phosphorylation of Mek and Erk was quantified by immunoblotting ( d ). The immunoblot signals were normalized to Tubulin ( b ) or to total Mek/Erk ( d ) and to the mean of two doxycycline-treated non-targeting control sgRNAs. qPCR measurements were normalized to two housekeeping genes and to the respective untreated control (−Dox). Dots and triangles depict individual measurements of the two different sgRNAs, and thick bars show the mean of three biological replicates. f Dusp9- and Klhl13 over-expressing mESCs were treated with 1 μg/ml doxycycline 24 h before differentiation via LIF withdrawal for 4 days, and expression levels of pluripotency factors were measured by qPCR at different time points as indicated. Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA). * p < 0.05 in a two-tailed paired Student’s t test comparing the Dusp9/Klhl13 over-expressing samples and the non-targeting controls (mean of sgRNA1 and sgRNA2)

Journal: Genome Biology

Article Title: Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach

doi: 10.1186/s13059-021-02321-2

Figure Lengend Snippet: Over-expression of Klhl13 and Dusp9 in male mESCs leads to an enhanced pluripotency state and slower differentiation kinetics. a Schematic representation of the dCas9-SunTag system used for gene activation. b–e To over-express Dusp9 (yellow) and Klhl13 (blue), male E14 mESCs, stably expressing the doxycycline-inducible SunTag system, were either transduced with one of two different sgRNAs targeting the respective promoter regions or with non-targeting control (NT) sgRNAs and were treated for 3 days with 1 μg/ml doxycycline as indicated. Protein levels of Dusp9 (left) and Klhl13 (right) were quantified via immunoblotting ( b ), expression levels of MAPK target genes Spry4 and Egr1 ( c ) and of naive pluripotency factors Nanog and Prdm14 ( e ) were assessed by qPCR and phosphorylation of Mek and Erk was quantified by immunoblotting ( d ). The immunoblot signals were normalized to Tubulin ( b ) or to total Mek/Erk ( d ) and to the mean of two doxycycline-treated non-targeting control sgRNAs. qPCR measurements were normalized to two housekeeping genes and to the respective untreated control (−Dox). Dots and triangles depict individual measurements of the two different sgRNAs, and thick bars show the mean of three biological replicates. f Dusp9- and Klhl13 over-expressing mESCs were treated with 1 μg/ml doxycycline 24 h before differentiation via LIF withdrawal for 4 days, and expression levels of pluripotency factors were measured by qPCR at different time points as indicated. Mean and standard deviation across 3 biological replicates is shown. g Global CpG methylation levels in cell lines over-expressing Dusp9 and Klhl13 via doxycycline treatment for 3 passages were assessed via pyrosequencing-based luminometric DNA methylation assay (LUMA). * p < 0.05 in a two-tailed paired Student’s t test comparing the Dusp9/Klhl13 over-expressing samples and the non-targeting controls (mean of sgRNA1 and sgRNA2)

Article Snippet: Since Dusp9 has been suggested to be responsible for the reduction of global CpG methylation levels typically observed in female mESCs (20–30% compared to 60–80% in male mESCs) [ , , ], we analyzed how over-expression of Dusp9 and Klhl13 affected global DNA methylation through the pyrosequencing-based luminometric DNA methylation assay (LUMA; Fig. g).

Techniques: Over Expression, Activation Assay, Stable Transfection, Expressing, Transduction, Control, Western Blot, Phospho-proteomics, Standard Deviation, CpG Methylation Assay, DNA Methylation Assay, Two Tailed Test